The Current Ratio as of November 2024 (TTM) for CollPlant Biotechnologies Ltd. (CLGN) is 6.27

According to CollPlant Biotechnologies Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 6.27. This represents a change of -25.94% compared to the average of 8.47 of the last 4 quarters.

CollPlant Biotechnologies Ltd. (CLGN) Historical Current Ratio (quarterly & annually)

How has CLGN Current Ratio performed in the past?

The mean historical Current Ratio of CollPlant Biotechnologies Ltd. over the last ten years is 5.29. The current 6.27 Current Ratio has changed 11.76% with respect to the historical average. Over the past ten years (40 quarters), CLGN's Current Ratio was at its highest in in the September 2021 quarter at 19.04. The Current Ratio was at its lowest in in the September 2017 quarter at 0.92.

CollPlant Biotechnologies Ltd. (CLGN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of CollPlant Biotechnologies Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

CollPlant Biotechnologies Ltd. (CLGN) Average Current Ratio

How has CLGN Current Ratio performed in the past?

The current Current Ratio of CollPlant Biotechnologies Ltd. (CLGN) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

CollPlant Biotechnologies Ltd. (CLGN) Current Ratio vs. Peers

How is CLGN’s Current Ratio compared to its peers?

CollPlant Biotechnologies Ltd.’s Current Ratio is less than Keros Therapeutics, Inc. (19.03), less than Merus N.V. (8.32), greater than Vericel Corporation (4.61), less than Century Therapeutics, Inc. (10.39), less than Shattuck Labs, Inc. (7.96), less than C4 Therapeutics, Inc. (6.31), less than Eliem Therapeutics, Inc. (60.41), less than Prelude Therapeutics Incorporated (7.04), greater than Monte Rosa Therapeutics, Inc. (6.03), less than Molecular Partners AG (14.33), less than MediciNova, Inc. (16.66), greater than Anebulo Pharmaceuticals, Inc. (3.45), greater than Champions Oncology, Inc. (0.69), less than Cyteir Therapeutics, Inc. (21.89), less than Replimune Group, Inc. (10.11), less than Crinetics Pharmaceuticals, Inc. (16.38), less than NewAmsterdam Pharma Company N.V. (10.61), greater than PureTech Health plc (3.68), less than Ikena Oncology, Inc. (15.32), greater than Enochian Biosciences, Inc. (0.08), greater than HCW Biologics Inc. (0.07), greater than Exicure, Inc. (0.71),

Build a custom stock screener for CollPlant Biotechnologies Ltd. (CLGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CollPlant Biotechnologies Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CollPlant Biotechnologies Ltd. (CLGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CollPlant Biotechnologies Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.